Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2006
03/23/2006US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren
03/23/2006US20060063811 Pyridinalkyl-aminoalkyl-ih-indole derivatives having an inhibitory action on 5-ht and serotonin reuptake as antidepressants and anxiolytics
03/23/2006US20060063809 Tri-substituted heteroaryls and methods of making and using the same
03/23/2006US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues
03/23/2006US20060063796 Pyrazoles as inhibitors of tumor necrosis factor
03/23/2006US20060063783 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors
03/23/2006US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
03/23/2006US20060063771 CCR5 antagonists useful for treating AIDS
03/23/2006US20060063770 Nitrogenous heterocyclic compounds
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity
03/23/2006US20060063741 Compounds useful as pesticides
03/23/2006DE112004000832T5 Lichtemittierende Polymerzusammensetzung Light-emitting polymer composition
03/23/2006DE102004036349A1 Substituierte 3-Phenylpiperidin-Derivate Substituted 3-phenyl piperidine derivatives
03/23/2006CA2787378A1 Method and apparatus for producing oxidized compound
03/23/2006CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/23/2006CA2580409A1 Triazole derivative or salt thereof
03/23/2006CA2580033A1 Imidazole compound
03/23/2006CA2580020A1 Aryl spirolactam cgrp receptor antagonists
03/23/2006CA2579847A1 Bicyclic anilide spirolactam cgrp receptor antagonists
03/23/2006CA2579665A1 Method and apparatus for producing oxidized compound
03/23/2006CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
03/23/2006CA2579143A1 Vanilloid receptor ligands and their use in treatments
03/23/2006CA2577181A1 Heteroaroyl-substituted serine amides utilized as herbicides
03/23/2006CA2568832A1 Indole derivatives as antiviral agents
03/22/2006EP1637566A1 Cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit
03/22/2006EP1637529A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof
03/22/2006EP1637524A1 10-substituted 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane derivative for use as contrast agents
03/22/2006EP1636221A2 New azetidine compounds
03/22/2006EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/22/2006EP1636207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636206A1 Imidazole derivatives as glutmate receptor antagonists
03/22/2006EP1636205A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors
03/22/2006EP1636197A1 Novel 3-substituted-1,4-benzodiazepines
03/22/2006EP1636195A1 Quinazolines and pyrido[3,4-d]pyrimidines as receptor tyrosine kinase inhibitors
03/22/2006EP1636193A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
03/22/2006EP1636189A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636187A1 Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636182A2 Prodrugs of mitotic kinesin inhibitors
03/22/2006EP1636181A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives
03/22/2006EP1635835A1 2-aminopyrimidine derivatives as raf kinase inhibitors
03/22/2006EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
03/22/2006EP1635821A2 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl)amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
03/22/2006EP1474417B1 Processes for preparing losartan and losartan potassium
03/22/2006EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain
03/22/2006EP1322635B1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
03/22/2006EP1309586B1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
03/22/2006EP1140924B1 Piperazine derivatives
03/22/2006EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/22/2006EP1107963B1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
03/22/2006CN1751052A Therapeutic agents
03/22/2006CN1751047A Triazole compounds useful in therapy
03/22/2006CN1751039A Pyridine derivatives as fungicidal compounds
03/22/2006CN1751038A Substituted aryl and heteroaryl derivatives as modulators of glucose metabolism and the prophylaxis and treatment of disorders thereof
03/22/2006CN1751028A Non-nucleoside reverse transcriptase inhibitors
03/22/2006CN1751025A Diamine derivatives
03/22/2006CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same
03/22/2006CN1751023A Piperidine-benzenesulfonamide derivatives
03/22/2006CN1750824A 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury
03/22/2006CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/22/2006CN1749255A 1,2,3,6-tetrahydro phthal-imide compound and their preparation and use
03/22/2006CN1246318C Process for preparation of imidazole compounds
03/22/2006CN1245979C Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient
03/22/2006CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient
03/21/2006US7015327 Anthrapyridone compound containing two phenyl rings substituted by sodium sulfonate groups; excellent in light fastness and water fastness
03/21/2006US7015241 Appetite-stimulating agents and remedies for anorexia
03/21/2006US7015237 Pyridine matrix metalloproteinase inhibitors
03/21/2006US7015235 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/21/2006US7015233 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
03/21/2006US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress
03/21/2006US7015228 4-amino-2-(2-pyridyl)pyrimidines as microbicidal active substances
03/21/2006US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases
03/21/2006US7015218 Amide compounds and medicinal use thereof
03/21/2006US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
03/21/2006US7015214 Such as 7-chloro-2-cyanoimino-5-(cyclopropylmethyloxy)-1,5-dihydro-5-trifluoromethyl-1,3-benzodiazepine
03/21/2006CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors
03/21/2006CA2315220C Integrin receptor antagonists
03/21/2006CA2270887C Methods and compositions for inhibition of angiogenesis
03/21/2006CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
03/21/2006CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
03/21/2006CA2139112C Novel nicotinic acid esters
03/21/2006CA2134625C Substituted pyridylsalicylaldehyde or -salicylic acid derivatives, their preparation and their use as herbicides
03/21/2006CA2124932C Sex steroid activity inhibitors
03/16/2006WO2006028964A1 Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
03/16/2006WO2006028958A2 Pyridyl inhibitors of hedgehog signalling
03/16/2006WO2006028957A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
03/16/2006WO2006028904A1 Quinazolines useful as modulators of ion channels
03/16/2006WO2006028590A1 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors
03/16/2006WO2006028226A1 Novel imidazolidine derivative and use thereof
03/16/2006WO2006027628A2 Naphthalimide derivatives as antiviral agents
03/16/2006WO2006027211A1 2,4-substituted pyrimidines as cysteine protease inhibitors
03/16/2006WO2006005609A3 Substituted oxindol derivatives and medicaments containing the same
03/16/2006WO2005123680B1 Six-membered heterocycles useful as serine protease inhibitors
03/16/2006WO2005121121A3 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/16/2006WO2005113535A3 Pyrazinylmethyl lactam derivatives
03/16/2006WO2005113494A3 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
03/16/2006WO2005100349A3 Polycyclic pyridines as potassium ion channel modulators
03/16/2006US20060058778 Novel compounds
03/16/2006US20060058570 Radioactive member and method of making
03/16/2006US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase